Literature DB >> 8372959

Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection.

M S Cetron1, F P Basilio, A P Moraes, A Q Sousa, J N Paes, S J Kahn, M H Wener, W C Van Voorhis.   

Abstract

Infection with Trypanosoma cruzi can cause chronic Chagas' disease manifestations (cardiac, gastrointestinal), although most persons with chronic infection have no ill effects (indeterminate form). Cell-mediated immunity (CMI) responses are believed to be intrinsically important in the containment of T. cruzi and in the pathogenesis of Chagas' disease. Humoral and CMI responses were investigated in 70 T. cruzi-infected persons from an endemic area in northeastern Brazil and in 30 uninfected controls. An epidemiologic survey, physical examination, and blood evaluation were conducted for each subject. The 70 chronically infected persons were subclassified into three clinical groups: indeterminate, cardiac, and gastrointestinal. Serum was tested for antibodies to T. cruzi by hemagglutination assay, indirect immunofluorescent assay, and enzyme-linked immunosorbent assay, and for autoantibodies to tubulin. Serum levels of soluble interleukin-2 receptor (sIL-2R), albumin, and C-reactive protein (CRP) were also measured to assess one parameter each of immunosuppression, nutritional status, and inflammation. The proliferative response of peripheral blood mononuclear cells (PBMC) to T. cruzi antigens, mitogen (phytohemagglutinin), and antigen-free controls was also assessed. Our data did not reveal any significant differences in serum levels of antibodies to T. cruzi, antibodies to tubulin, albumin, CRP, or sIL-2R among the subgroups of infected individuals. The data demonstrate differences in CMI responses. Trypanosoma cruzi trypomastigote lysate stimulated proliferation of PBMC from infected persons, but not uninfected controls. Patients with symptomatic Chagas' disease (cardiac and gastrointestinal groups) had decreased cellular responses to T. cruzi lysate (median proliferation index [PI] = 3), compared with those in the indeterminate group (median PI = 9; P < 0.005). Further investigations of the mechanism of this reduced CMI response in those with chronic disease may yield insights into the pathogenesis of Chagas' disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8372959     DOI: 10.4269/ajtmh.1993.49.370

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  5 in total

Review 1.  Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine.

Authors:  Silvia Gilka Muñoz-Saravia; Annekathrin Haberland; Gerd Wallukat; Ingolf Schimke
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

2.  Environmental toxicants in developing countries.

Authors:  P Ostrosky-Wegman; M E Gonsebatt
Journal:  Environ Health Perspect       Date:  1996-05       Impact factor: 9.031

3.  Cellular immune response from Chagasic patients to CRA or FRA recombinant antigens of Trypanosoma cruzi.

Authors:  Virginia M B Lorena; Alinne F A Verçosa; Raquel C A Machado; Lucas Moitinho-Silva; Maria G A Cavalcanti; Edimilson D Silva; Antonio G P Ferreira; Rodrigo Correa-Oliveira; Valéria R A Pereira; Yara M Gomes
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

Review 4.  Is It Possible to Intervene in the Capacity of Trypanosoma cruzi to Elicit and Evade the Complement System?

Authors:  Galia Ramírez-Toloza; Lorena Aguilar-Guzmán; Carolina Valck; Smrithi S Menon; Viviana P Ferreira; Arturo Ferreira
Journal:  Front Immunol       Date:  2021-12-16       Impact factor: 7.561

5.  Trypanosoma cruzi vaccine candidate antigens Tc24 and TSA-1 recall memory immune response associated with HLA-A and -B supertypes in Chagasic chronic patients from Mexico.

Authors:  Liliana E Villanueva-Lizama; Julio V Cruz-Chan; Amarú Del C Aguilar-Cetina; Luis F Herrera-Sanchez; Jose M Rodriguez-Perez; Miguel E Rosado-Vallado; Maria J Ramirez-Sierra; Jaime Ortega-Lopez; Kathryn Jones; Peter Hotez; Maria Elena Bottazzi; Eric Dumonteil
Journal:  PLoS Negl Trop Dis       Date:  2018-01-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.